Publication:
Acute effect of zoledronic acid infusion on atrial fibrillation development in patients with osteoporosis

Simple item page
dc.contributor.authorÇİNÇİN, AHMET ALTUĞ
dc.contributor.authorsIlgezdi, Zeynep Demet; Aktas, Ilknur; Metin, Fatma Dogan; Kepez, Alper; Ozkan, Feyza Unlu; Silte, Ayse Duygu; Kaysin, Meryem Yilmaz; Kivrak, Tarik; Cincin, Altug; Erdogan, Okan
dc.date.accessioned2022-03-14T11:03:39Z
dc.date.available2022-03-14T11:03:39Z
dc.date.issued2015-04-09
dc.description.abstractObjective: There is ongoing controversy related to the relationship between bisphosphonates and atrial fibrillation (AF). Our aim in this study was to evaluate the potential acute effect of zoledronic acid (ZA) infusion on AF development by using 24-hour Holter recordings. Methods: The study was designed to be a self-controlled case series study, and 33 consecutive patients with osteoporosis (29 females, age: 62.3 +/- 9.0 years) who were scheduled to receive ZA infusion constituted the study population. Patients underwent 24-hour Holter rhythm recordings at two different times; the first one was 48 hours before the planned ZA infusion, and the second one was on the morning of the infusion day. Heart rate, frequency and type of arrhythmias, as well as heart rate variability (HRV) from the two recordings were compared. Results: There were no episodes of AF greater than 30 sec in any of the 24-hour Holter recordings obtained before and on the day of drug infusion. Holter recordings before drug infusion showed that only 1 patient had an atrial run of 3 beats long. Holter recordings obtained on the day of drug infusion revealed that 5 patients (15.2%) had atrial runs with lengths ranging between 3 and 12 beats (p=0.046). Regarding HRV variables, SDANN values were found to be significantly depressed on the day of ZA infusion (113.6 +/- 26.9 vs. 98.2 +/- 29.9, p=0.007). Conclusion: None of the patients developed AF during or early after ZA infusion. However, there was an increase in atrial ectopy in some patients, which might be due to alterations in cardiac autonomic activity.
dc.identifier.doi10.5152/akd.2014.5333
dc.identifier.eissn2149-2271
dc.identifier.issn2149-2263
dc.identifier.pubmed25413229
dc.identifier.urihttps://hdl.handle.net/11424/245811
dc.identifier.wosWOS:000355106500010
dc.language.isoeng
dc.publisherAVES
dc.relation.ispartofANATOLIAN JOURNAL OF CARDIOLOGY
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectosteoporosis
dc.subjectzoledronic acid
dc.subjectatrial fibrillation
dc.subject24-hour Holter recording
dc.subjectSAFETY
dc.subjectBISPHOSPHONATES
dc.subjectALENDRONATE
dc.subjectFRACTURES
dc.titleAcute effect of zoledronic acid infusion on atrial fibrillation development in patients with osteoporosis
dc.typearticle
dspace.entity.typePublication
local.avesis.ide228d4df-54c4-4437-a7b1-d4eed35febfa
local.import.packageSS16
local.indexed.atWOS
local.indexed.atSCOPUS
local.indexed.atTRDIZIN
local.journal.numberofpages5
oaire.citation.endPage324
oaire.citation.issue4
oaire.citation.startPage320
oaire.citation.titleANATOLIAN JOURNAL OF CARDIOLOGY
oaire.citation.volume15
relation.isAuthorOfPublication54255a29-54c0-43de-8bc5-39d805d1296a
relation.isAuthorOfPublication.latestForDiscovery54255a29-54c0-43de-8bc5-39d805d1296a

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Ilgezdi et al. - 2015 - Acute effect of zoledronic acid infusion on atrial.pdf
Size:
111.87 KB
Format:
Adobe Portable Document Format
Download

Collections

Research Outputs